These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6354421)

  • 41. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
    Santinami M; Belli F; Cascinelli N; Rovini D; Vaglini M
    J Surg Oncol; 1989 Nov; 42(3):201-8. PubMed ID: 2811386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation perfusion for malignant melanoma of the extremity: a review.
    Cumberlin R; De Moss E; Lassus M; Friedman M
    J Clin Oncol; 1985 Jul; 3(7):1022-31. PubMed ID: 2410572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated regional perfusion in the treatment of subungual melanoma.
    Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis JW; Oldhoff J
    Arch Surg; 1989 Mar; 124(3):373-6. PubMed ID: 2645858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional hyperthermic perfusion for malignant melanoma.
    Hafström LO; Ehrson H; Hugander A; Jönsson PE; Westling H
    Prog Clin Biol Res; 1982; 107():793-8. PubMed ID: 7167529
    [No Abstract]   [Full Text] [Related]  

  • 45. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents.
    Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis WJ; van der Weele LT
    Cancer; 1989 Jan; 63(1):199-203. PubMed ID: 2910418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
    Schraffordt Koops H; Oldhoff J
    Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
    Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
    Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy by regional perfusion for limb melanoma.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH
    Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
    Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
    J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Results of regional isolated perfusion for locally inoperable melanoma of the limbs.
    Kapteijn BA; Klaase JM; van Geel AN; Eggermont AM; Kroon BB
    Melanoma Res; 1994 Apr; 4(2):135-8. PubMed ID: 8069099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.
    Ghussen F; Nagel K; Groth W; Müller JM; Stützer H
    Ann Surg; 1984 Dec; 200(6):764-8. PubMed ID: 6508407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxics and hyperthermic perfusion: a preliminary study.
    Tonak J; Hermanek P; Banz H; Groitl H
    Cancer Treat Rev; 1979 Jun; 6 Suppl():135-41. PubMed ID: 498167
    [No Abstract]   [Full Text] [Related]  

  • 54. Results of 206 isolated limb perfusions for malignant melanoma.
    Lejeune FJ; Liénard D; el Douaihy M; Seyedi JV; Ewalenko P
    Eur J Surg Oncol; 1989 Dec; 15(6):510-9. PubMed ID: 2599121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)].
    Hafström L; Jönsson PE
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351
    [No Abstract]   [Full Text] [Related]  

  • 57. Results of cisplatin hyperthermic isolation perfusion for stage IIIA and IIIAB extremity melanoma.
    Fletcher WS; Pommier R; Small K
    Melanoma Res; 1994 Mar; 4 Suppl 1():17-9. PubMed ID: 8038590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.